>>> Fox Sports signs multi-year rights agreement with MLB; no financial terms di

Fox Sports signs multi-year rights agreement with MLB; no financial terms disclosed
- FOX Sports and Major League Baseball have reached a new multi-year, multiplatform rights agreement expanding the network’s television, digital and Spanish-language rights and cementing FOX Sports as the home to baseball’s marquee events for the next decade. The agreement was announced today by Baseball Commissioner Robert D. Manfred, Jr. and Executive Chairman of 21CF Lachlan Murdoch.
- FOX Sports and FOX Deportes maintain the television rights to MLB’s jewel events, including serving as the exclusive television broadcast partner of the World Series, one League Championship Series, two Division Series and the All-Star Game. The network’s League Championship Series and Division Series coverage will remain the same as it’s been since 2014, alternating leagues each season. As in previous agreements, MLB Network will continue to have the rights to two games from the League’s Division Series that FOX is airing. Under terms of the new deal, FOX Sports will also expand its digital rights.- Under the new agreement, FOX Sports continues its Saturday regular-season broadcast windows – two per Saturday (52 total)
– with highlights packages as well as MLB-centric programs and Spanish-language rights through FOX Deportes. Beginning in 2022, the amount of regular season and postseason games televised by the FOX broadcast network will increase.
- In addition, the new MLB and FOX agreement will include expanded streaming, social media and highlight rights. FOX also will televise special event games to be determined over the term of the agreement.

WSJ : Oil Hedge Fund Giant Hammered in Crude’s Slide

Oil Hedge Fund Giant Hammered in Crude’s Slide
Pierre Andurand, who runs one of the last big oil-focused hedge funds, took significant losses in October as petroleum prices cratered

One of the last oil hedge funds standing has become a high-profile victim of the recent rout in crude prices.

Pierre Andurand, who earlier in 2018 predicted oil could soon hit $100 a barrel, suffered the largest-ever monthly loss of his flagship fund in October. The $1 billion Andurand Commodities Fund lost 20.9% last month, taking the fund down more than 12% for the year, according to numbers sent to investors and reviewed by The Wall Street Journal.

A spokesman for Mr. Andurand declined to comment on the performance of the fund.

The losses are due to a dramatic U-turn in oil prices since a peak in early October, as fears of oversupply engulfed the market. The Trump administration granted waivers to some buyers of Iranian crude, softening sanctions against Tehran that went into effect in November and were predicted to push prices higher.

Brent, the global benchmark, entered a bear market this month—defined as a 20% drop from a recent peak—and on Thursday, Brent was trading at $66.67 a barrel, near its lowest point since March.

Oil prices took a dramatic plunge Tuesday, with U.S. crude sliding 7.1%, its steepest fall in over three years. That led to market speculation that a large hedge fund had got into trouble, with some pointing the finger at Mr. Andurand’s fund.

“It was nothing to do with us,” Mr. Andurand told The Wall Street Journal on Wednesday. “I do not think the move is related to large funds in trouble.”

In a call with investors Tuesday, which lasted around 40 minutes, Mr. Andurand didn’t discuss performance, according to people familiar with the call. Mr. Andurand said he had believed that President Trump would go through with sanctions against Iran, but when lot of the market was exempted, he started to take off risk.

In June, Mr. Andurand, who runs his fund out of offices opposite London luxury department store Harrods, said that oil prices were in a “multiyear bull run” and could hit $100 in 2018, a level unseen since 2014. He also said that prices could hit as high as $300 a barrel in a few years, although that wasn’t his forecast.

Prices initially followed his prediction. Brent broke above $86 a barrel in early October, its highest level in four years.

However, then crude prices quickly reversed on news of the Iran waivers and U.S. oil production hitting record highs. Brent lost nearly 9% in October and continued to fall into November.

Years of choppy and often falling markets have obliterated a once-prominent group of hedge funds, collectively running billions of dollars, that bet on commodities. Among firms that have shut commodities funds are Astenbeck Capital Management, Armajaro Asset Management, Clive Capital, Centaurus Capital and Brevan Howard.

Mr. Andurand, a kickboxing devotee with a reputation for aggressive trades, made his name during the 2008 financial crisis when his previous fund, BlueGold Capital, made a staggering 209% that year, after betting against oil in the final four months of the year, as Lehman Brothers collapsed and oil lost more than half its value.

Mr. Andurand’s new fund, the Andurand Commodities Fund, has gained every year since its 2013 inception, helped by bullish bets, including buying one day after oil hit a 13-year low in 2016. That year, the fund gained 22.1%. The fund is still up around 100% since its start.

WWD : Personal Luxury Goods Expected to Grow Up to 5% Per Year Until 2025

Personal Luxury Goods Expected to Grow Up to 5% Per Year Until 2025
This would mean a forecast of total revenues of between 320 billion euros and 365 billion euros in 2025.

MILAN — Sales of personal luxury goods are expected to post an average yearly growth of 3 percent to 5 percent at constant exchange rates from 2018 until 2025, according to the Bain & Company Luxury Goods Worldwide Market Study released on Thursday as part of the Altagamma Worldwide Luxury Market Monitor.

This would mean a forecast of total revenues of between 320 billion euros and 365 billion euros in 2025. The study expects the growth will be driven by “solid fundamentals” and the attitude of global consumers.

Bain does not rule out some “turbulence” in the near future, such as a soft recession in the U.S. and a slight slowdown of the Chinese economy, but this “does not detract from the solid potential of the future market.”

The personal luxury goods market is expected to close 2018 with revenues of 260 billion euros, a 2 percent increase compared with 2017. At constant exchange rates, the growth is forecast to reach 6 percent.

All geographic markets showed growth, with the exception of the Middle East, which was stable. China logged in a “particularly positive trend” and was driven by local purchases, as Chinese tourism was less strong in Europe. The rest of Asia was also strong, led by local shopping and increased Chinese shoppers spending in nearby countries.

The online channel is accelerating, with a 10 percent penetration of the global market.

Jewelry and shoes are the top categories, while apparel was down 1 percent, due mainly to the slowdown of the accessible luxury giants, especially in the men’s wear segment.

The luxury goods sector is expected to log 5 percent growth at constant exchange rates to 1.2 trillion euros in 2018. Next year, sales of personal luxury goods are expected to grow around 5 percent.

>>> Wal-Mart will report Q3 results tomorrow morning

Wal-Mart will report Q3 results tomorrow morning

Wal-Mart (WMT) will report third quarter (October) results tomorrow morning around 7:00 followed by a pre-recorded call, management commentary and a presentation on its website.
The strong US consumer is providing a strong tailwind for the nation's largest brick and mortar retailer. Last quarter, Wal-Mart reported its best comparable store sales in more than a decade. Wal-mart US comps accelerated 240 basis points sequentially to 4.5%, handily beating estimates. The company's omnichannel and digital priorities that are delivering results as eCommerce sales grew 40%.
The Street expects Q3 EPS of $1.02 (vs. $1.00) last year with net sales (excluding membership fees) up 2% to $124.4 billion and comps up 3%.
At its Annual Meeting last month, Wal-Mart updated guidance for fiscal 2019 (January) to account for dilution from the Flipkart acquisition. Wal-Mart lowered FY19 EPS to $4.65-4.80 from $4.90-5.05 (vs. $4.42 last year). In August, the company raised constant currency net sales growth to ~2% from +1.5-2.0% while raising Walmart US comp sales (ex-fuel) to ~3% from at least 2% and Sam's comps to ~3% from flat to down 1% despite a 200 bps negative impact from tobacco. Capital IQ Consensus calls for FY19 EPS +8% to $4.79 with net sales up 3% to $512 billion, Wal-Mart US comps +3.2% and gross margin down slightly at 24.5%.
The company also gave preliminary guidance for fiscal 2020 at its Annual Meeting. Wal-Mart guided for FY20 sales growth to be 3% or greater, negatively affected by about 100 basis points due to the deconsolidation of the Brazil operations and planned reduction in tobacco sales at Sam's Club. Walmart U.S. comp sales growth is expected to be in a range of 2.5-3.0% and eCommerce net sales growth is expected to be around 35%. FY20 operating income is expected to decline by a low single digit percentage range, but is expected to increase by a low single digit percentage range when excluding Flipkart in both FY19 and FY20. FY20 EPS is expected to decline by a low single digit percentage range versus FY19 adjusted EPS. Excluding Flipkart, EPS is expected to increase by a low to mid-single digit percentage range versus FY19 adjusted EPS.
Wal-Mart continues to invest in online growth channels and overseas markets to expand its retail presence globally, which will weigh on bottom line over the intermediate term. Investors seem to be ok with that while core results remain strong.
Wal-Mart has a $298 billion market cap and trades at 21x EPS, a premium to Kroger (KR) at 14x and Target (TGT) at 15x but a discount to wholesaler Costco (COST) at 30x. The weekly options imply a ~5% move in the stock by Friday. Note that US retail sales for October will also be released tomorrow morning at 8:30.

>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
:

  • MARK -39% (also provides debt repayment update and strategic alternatives exploration news), JCP -12.3%, NTAP -5.8%, CPA -5.7%, LXFT -3.2%

Other news:

  • HSDT -12.3% (proposes public offering of Class A common stock)
  • EYE -4.3% (announces secondary offering of 12.5 mln shares of common stock by shareholders)
  • KREF -4.1% (prices 4.5 mln common stock offering for gross proceeds of approximately $10 million to the company and approximately $80 million from the sale of the Secondary Shares)
  • NGHC -3.8% (prices public offering of 5 mln shares of common stock at $24.00 per share)
  • AGNC -2.6% (announces public offering of 40.0 mln shares of common stock)
  • ED -2.5% (prices offering of 13,636,363 common shares at $77.00 per common share)

Analyst comments:

  • CPA -5.7% (downgraded to Neutral from Buy at Citigroup)
  • LW -1.2% (downgraded to Neutral from Buy at BofA/Merrill)

>>> US Gapping up

Gapping up
In reaction to disappointing earnings/guidance
:

  • NBEV +18.2%, TNK +7.5%, VIPS +6.5%, EZPW +6.5%, NTES +5.1%, CSCO +4.7%, WUBA +3.2%, SFS +3%, CSIQ +2.5%, WMT +1.6%, TGP +1.2%, .

Other news:

  • QURE +25% (initial clinical data in patients treated in the Company's Phase IIb dose-confirmation study of AMT-061 for the treatment of patients with severe and moderately severe hemophilia B)
  • ARNA +21.2% (Arena Pharm and United Therapeutics (UTHR) enter into a global license agreement for Arena's ralinepag in development for the treatment of pulmonary arterial hypertension)
  • EXEL +5.9% (partner Ipsen receives EC approval for CABOMETYX; triggers $40 mln milestone payment to Exelixis)
  • COTY +3.4% (Soros discloses new stake)
  • ORCL +3.4% (Berkshire Hathaway discloses new stake in quarterly update)
  • SUN +3.3% (American Midstream Partners (AMID) to sell its refined products terminalling business to Sunoco (SUN) for approximately $125 million in cash)
  • SVMK +2.4% (continued strength following earnings/Tiger Global stake disclosure)
  • JPM +1.6% (Berkshire Hathaway discloses new stake in quarterly update)
  • MNK +1.6% (Mallinckrodt's SpecGx confirms outcome of FDA Joint Advisory Committee on abuse-deterrent, immediate-release reformulation of Roxicodone)
  • SYMC +1.5% (Starboard, ValueAct and Glenview disclose new holding in quarterly update), ET +1% (after CEO disclosed the purchase of 2 mln shares)

Analyst comments:

  • SWCH +3.4% (upgraded to Strong Buy from Mkt Perform at Raymond James)
  • CUBE +1.2% (upgraded to Buy from Neutral at BofA/Merrill)

>>> US Early premarket gappers

Early premarket gappers

Gapping up:

  • TNK +6.6%, VIPS +6.5%, EZPW +6.5%, NTES +5.6%, NBEV +5.4%, CSCO +5.2%, WUBA +4%, SVMK +3.8%, COTY +3.4%, SFS +3%, ORCL +2.9%, JPM +1.8%, MNK +1.6%, SYMC +1.5%, WMT +1.4%, TGP +1.2%, ET +1%, CSIQ +1%, BAC +0.7%, HAIN +0.5%

Gapping down:

  • MARK -36%, HSDT -12.3%, NTAP -6.3%, CPA -4.3%, KREF -3.6%, NGHC -3%, AGNC -2.9%, ED -2.3%, VICI -1.1%, FE -0.9%, ZTO -0.5%